Evidence map›Paper›PMID 33052426›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2020

Effects of vitamin B12 on methotrexate hepatotoxicity: evaluation of receptor-interacting protein (RIP) kinase.

Derya Karabulut, Emel Ozturk, Nurhan Kuloglu, Ali Tuğrul Akin, Emin Kaymak, Birkan Yakan

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Effect of vitamin B12 on methotrexate-induced cardiotoxicity in rats.Iranian journal of basic medical sciences · 2024
    Article
  7. Potential Hepatoprotective Effects ofAntioxidants (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Derya KarabulutHistology-Embriology Department, Faculty of Medicine, Erciyes University, Köşk, Talas Avenue, 38030 Melikgazi-, Kayseri, Turkey. deryakkus@hotmail.com.ORCID https://orcid.org/0000-0003-2067-6174
Emel OzturkHistology-Embriology Department, Faculty of Medicine, Harran University, Sanlıurfa, Turkey.
Nurhan KulogluHistology-Embriology Department, Faculty of Medicine, Erciyes University, Köşk, Talas Avenue, 38030 Melikgazi-, Kayseri, Turkey.
Ali Tuğrul AkinBiology Department, Faculty of Science, Erciyes University, Kayseri, Turkey.
Emin KaymakHistology-Embriology Department, Faculty of Medicine, Bozok University, Yozgat, Turkey.
Birkan YakanHistology-Embriology Department, Faculty of Medicine, Erciyes University, Köşk, Talas Avenue, 38030 Melikgazi-, Kayseri, Turkey.
Erciyes University · TRHarran University · TRNiğde Ömer Halisdemir Üniversitesi · TRYozgat Bozok Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the study, we aimed to show the effects of vitamin B12 on the necrosis caused by methotrexate (MTX), a folic acid antagonist. Thirty-two rats were randomly assigned to four groups of eight rats per group. Control (n = 8), Vit B12 (n = 8) 3 μg/kg/ip B12 (15 days) per day throughout the experiment, MTX (n = 8) injected with a single dose of 20 mg/kg/ip MTX on 8th day of experiment, MTX + Vit B12 (n = 8) injected with a single dose of 20 mg/kg ip methotrexate on 8th day of experiment + 3 μg/kg/ip Vit B12 (15 days) per day throughout the experiment. Oxidant (TOS)/antioxidant (TAS) system, TNF-α and TGF-β levels, AST and ALT, serum vitamin B12 levels were determined in the tissue. Cyclooxygenase-2 (Cox-2), receptor-interacting protein kinase 1 (RIP1) and 3 (RIP3) immunohistochemistry were applied to the liver tissue. TOS increased; TAS decreased; TNF-α and TGF-β levels increased; AST and ALT levels changed after MTX hepatotoxicity. Vit B12 decreased significantly. COX-2, RIP1, and RIP3 immunoreactivity increased. Vit B12 showed improvement in all of the negative results. Vit B12 is an important supplement to be used against necrosis in tissue after MTX hepatotoxicity.

Indexed as

AnimalsAntimetabolites, AntineoplasticChemical and Drug Induced Liver InjuryMaleMethotrexateRatsRats, WistarReceptor-Interacting Protein Serine-Threonine KinasesTreatment OutcomeVitamin B 12Antimetabolites, AntineoplasticMethotrexateReceptor-Interacting Protein Serine-Threonine KinasesVitamin B 12MethotrexateReceptor-interacting protein kinaseVitamin B12

Identifiers

PMID33052426
OpenAlexW3092548309

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.